IAIurii Arian

Iurii Arian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iurii Arian has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rolul uretritelor nongonococice de etiologie bacteriană în infertilitatea masculină

    by Iurii Arian, Daniela-Patricia Covali, Ion Dumbraveanu, Alan Bogdanov, Gabriela Scripnic, Constantin Tataru

    The article presents original data as well as a review of recent literature on the potential impact of male genital tract infections, particularly non-gonococcal urethritis on male infertility. The retrospective study included 200 patients from infertile couples who experienced unexplained infertility. They were separated into two groups: 100 patients with sexually transmitted infections and 100 patients with no infection. Spermograms, inflammatory state, and endocrine indicators were all examined in both groups. In 37 (37%) of the men, a single infection with Ureaplasma urealyticum/parvum was identified, in 24 (24%) with Gardnerella vaginalis, in 32 (32%) with both Ureaplasma urealiticum/parvum and Gardnerella vaginalis, in 9 (9%) with Mycoplasma hominis, and in 8 (8%) with Mycoplasma genitalium. Comparative analysis of the groups revealed statistically significant differences (p < 0.05) in ejaculate volume, pH, total sperm count, concentration, total motility, progressive motility, and sperm vitality, with significantly lower values in the study group compared to the control group. Infection with Ureaplasma spp., either alone or in combination with other non-gonococcal infections, has a significant impact on ejaculate volume, pH, total sperm count, concentration, vitality, total motility, and progressive motility of spermatozoa compared to the control group.

  • Open Access

    Evaluarea integrată a vârstei, psa și scorului pi-rads în corelație cu rezultatul histopatologic în cancerul de prostată

    by Iurii Arian, Stanislav Balan, Karabacak Ozcan Yasin, Alexandru Piterschi, Andrei Galescu, Ion Dumbraveanu

    Re-biopsy evaluation of prostate cancer relies on the integration of clinical, biological, and imaging parameters; however, the relative contribution of age, total PSA, and the PI-RADS score in correlation with histopathological outcomes requires further clarification. This retrospective study included 218 patients evaluated by multiparametric prostate magnetic resonance imaging and prostate biopsy, for whom complete data on age, total PSA, PI-RADS score, and histopathological results were available. Clinically significant prostate cancer was defined as adenocarcinoma with a Gleason score ≥7. Statistical analysis included univariate and multivariate logistic regression, as well as assessment of discriminatory performance using the area under the receiver operating characteristic curve (AUC). Prostate cancer was identified in 73.9% of patients, with clinically significant forms in 53.7%. Age, analyzed as a continuous variable, showed no significant association with either the presence of malignancy or clinically significant prostate cancer. Total PSA was associated with histopathological outcomes, while the PI-RADS score demonstrated the highest discriminatory ability for prostate cancer and for Gleason score ≥7 (p < 0.001). In multivariate analysis, the inclusion of PSA and PI-RADS improved the model’s discriminatory performance compared with univariate models (AUC = 0.75–0.76). Age was not significantly correlated with histopathological outcomes. The combined use of total PSA and PI-RADS score allows more accurate pre-biopsy oncological risk stratification and supports the use of multiparametric magnetic resonance imaging in the evaluation of patients prior to prostate biopsy.

  • Open Access

    Multiparametric descriptive and comparative analyses between fertile versus infertile men with severe oligozoospermia and azoospermia

    by Iurii Arian, Alan Bogdanov, Karabacak Ozcan Yasin, Ion I. Dumbrăveanu, Ion Dumbraveanu, Andrei Chiriac

    Male infertility represents a major global health concern, often associated with conditions such as severe oligoasthenoteratozoospermia and azoospermia. The aim of the study was to compare clinical, biochemical, and genetic characteristics between infertile men and fertile controls. A prospective case-control study was conducted involving 180 participants, including 90 infertile men (45 with severe oligoasthenoteratozoospermia and 45 with azoospermia) and 90 fertile controls. Semen analysis, testicular ultrasound, vitamin D levels, and genetic testing.were performed. In men with severe oligoasthenoteratozoospermia, significantly reduced mean values were observed for sperm concentration (1.77±2 million/mL), total sperm count (5.59±8 million), total motility (12.64±16%), progressive motility (7.93±12%), vitality (13.64±18%), and normal morphology (1.02±2%) compared to controls. Vitamin D levels were slightly higher in the study group (29.37±9.3 ng/mL) than in controls (25.38±10.2 ng/mL). Average testicular volumes were 12.50±5.47 mL (right) and 12.30±5.09 mL (left). Abnormal echotexture and echogenicity were noted in 24.6% and 31.5% of right testes and 15.6% and 25.5% of left testes, respectively. Y chromosome microdeletions (sY242, sY1291, sY255, sY254) were identified in 4.4% of cases. An abnormal karyotype was found in 7.8% of infertile participants, while 92.2% had a normal karyotype. Compared with fertile men, severe oligoasthenozoospermia and azoospermia show marked alterations in semen, testicular, genetic, and endocrine parameters.

  • Open Access

    Sindromul MOSH – o nouă viziune a hipogonadismului dobândit

    by Victoria Ghenciu, Arian Iurii, Ion Dumbraveanu, Mariana Creciun, Emil Ceban

    Functional male hypogonadism in association with obesity has recently been defined as secondary obesity-induced hypogonadism – MOSH syndrome. Сlinical manifestations are explained by two important mechanisms: testosterone deficiency and excess adipose tissue. Synthesis of 50 articles predominantly of the last 10 years from databases: Google Scholar, PubMed, Research Gate, Wiley Online Library, Health Data Science using keywords – „MOSH”, „hypogonadism”, „obesity”, „male sex-reproductive dysfunction”, „infertility”. The prevalence of MOSH in the general population is 45% and correlates positively with the degree of obesity. Multifactorial pathogenetic mechanisms include lipotoxicity, suppression of the hypothalamic-pituitary-gonadal axis, leptinresistance, hyperestrogenemia, oxidative stress, proinflammatory status, metabolic insulinoresistance and endotoxemia, sleep apnea, genetic and epigenetic changes, etc, with major impact on male sexual-reproductive health. Treatment strategy includes decrease in body mass, which can relieve the symptoms of androgen deficiency, improve metabolic profile and fertility. MOSH is a subtype of functional hypogonadism with reversible potential with substantial weight loss.

  • Open Access

    Hipogonadismul bărbatului în vârstă. Repere de diagnostic și tratament

    by Ion Dumbraveanu, Iurii Arian, Victoria Ghenciu, Mariana Creciun, Emil Ceban

    Late-onset hypogonadism (LOH) is the most controversial form of hypogonadism and an unsolved problem. Its prevalence is unknown, it is estimated as being at least 1 in 5 men after 40 years, and about 80% of those with comorbidities may have hypogonadism. LOH does not have age-defined criteria and may be included in its start-out and developing mechanisms elements of primary hypogonadism due to insufficient testicular function and secondary. When preparing this article, the reviews of 40 analytical studies and international guidelines of the European Academy of Andrology and the Societies of Endocrinology and Urology were consulted. This type of hypogonadism is dependent on the age and men’s health status. Decreased testosterone levels can be the result of chronic disease, diabetes, organ failure, or obesity. Or because of the presence of chronic systemic inflammation. Older patients with signs of testosterone deficiency need an individual approach to establish the presence of a reversible/ functional form of hypogonadism that can be ameliorated with other remedies than testosterone replacement therapy. After clinical and biochemical confirmation of hypogonadism, testosterone treatment recommended recommended only with an evaluation of potential benefits and risks.


  • Open Access

    Provocări actuale în diagnosticul și tratamentul deficitului de testosteron la bărbații de vârstă reproductivă

    by Iurii Arian, Ion Dumbraveanu, Victoria Ghenciu, Alan Bogdanov, Mariana Creciun, Emil Ceban

    Currently, an increasing number of young and middle-aged men are seeking treatment for symptoms related to low testosterone levels, which include depression, chronic fatigue, low libido, erectile dysfunction and/or infertility. In situations where conceiving a child is not a short- or medium-term goal, the preservation of reproductive function needs to be considered in the context of the treatment offered. Testosterone deficiency is often of unknown origin especially in men of reproductive age, and the choice of treatment method becomes even more difficult, in the context where the scientific evidence and degree of recommendation of various treatments is weak. Literature review was performed using major databases including PubMed, Hinari, SpringerLink and Scopus (Elsevier). One third of infertile men under the age of 50 were found to be hypogonadal. Correlation of spermogram result with testosterone level identified deficiency in 16.7% of men with obstructive azoospermia, 45% of men with non-obstructive azoospermia, 42.9% of men with oligozoospermia and/or asthenozoospermia and 35.3% of men with normal sperm parameters. Testosterone replacement therapy, although effective in addressing most symptoms of hypogonadism, has negative effects on testicular function. Counseling should include a thorough discussion of risks and benefits with an emphasis on spermatogenesis suppression for men of reproductive age who wish to maintain their reproductive potential.

  • Open Access

    Efectele substanțelor auxiliare folosite în dopaj asupra funcţiei sexual-reproductive masculine

    by Mariana Creciun, Victoria Ghenciu, Iurii Arian, Constantin Tataru, Ion Dumbraveanu

    Using pharmacological substances to enhance athletic performance, known as doping, is widespread in sports and bodybuilding. Doping involves substances such as anabolic steroids, selective androgen receptor modulators, peptide hormones, beta-2 adrenergic agonists, and other auxiliary substances that temporarily enhance physical performance. Although perceived as safer alternatives to traditional steroids, they pose significant health risks, including on male reproductive function. The literature was reviewed using electronic databases such as PubMed, Scopus, and Google Scholar, Out of 296 articles published until 2024, 30 were included in the study providing data on the effects of these substances on sexual-reproductive function. Although SARMs do not have adverse effects like steroids, their excessive use can suppress endogenous testosterone production, affecting spermatogenesis. Peptide hormones and beta-2 adrenergic agonists can disrupt hormonal balance, affecting the hypothalamic-pituitary-gonadal (HPG) axis, suppressing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Myostatin inhibitors and excessive consumption of amino acid derivatives can cause hormonal imbalances and oxidative stress, affecting the quality of seminal material. Auxiliary substances with anabolic effects used in doping can have significant adverse effects on male reproductive health, such as suppression of the HPG axis, decreased testosterone, and impaired spermatogenesis. Further studies are needed to understand the exact mechanisms and long-term impact of these substances on reproductive health.


  • Diagnostic evaluation and therapeutic management of the male in the infertile couple

    by Ion Dumbraveanu, Iurii Arian, Victoria Ghenciu, Mariana Creciun, Andrei Bradu, Mihaela Ivanov, Emil Ceban

    About 15-20 % couples have no children or have not enough than they want. About 50 % of the causes infertility in the couple its related to the male etiological factor. Only 60 -70 % of the causes of male infertility are known, 40 % is considered idiopathic or unexplained. The diagnostic and therapeutic management of the male infertility is permamently addapted to new scientific discoveries. The purpose of the article is a analaisys of the methods of diagnostic and treatment of male infertility through the the scientiphic discovery acording to the data providen in international guidelines. Male infertility has multiple etiological factors (urology, endocrine, genetic) and requires a adequate evaluation, which is not limited to spermogram analasys. In case of infertile couple, the male must be examined totaly not only to elucidate and treat the etiological factors involved, but to diagnose other concomitent other than urologic disorder with potential consequences for the futher quality and duration of life.

  • Male fertility preservation at risk of gonadotoxicity

    by Iurii Arian, Mihaela Monacu, Ion Ernu, Daniela Machidon, Ion Dumbraveanu

    Background: Along with other aspects of male reproduction, fertility preservation has made significant advances in the past ten years. The overall survival rate for childhood cancer has greatly improved in recent decades, with a current 5-year survival rate of over 80%, compared to roughly 58% in the late 1970s. Many of the most common reproductive issues, such as cryptorchidism and hypospadias in newborns as well as testicular cancer and lower sperm quality in young adult males, have recently become increasingly common. Although the precise cause of these unfavorable effects on reproduction is yet unknown, it has been suggested that they may be related to the presence of common chemicals in the environment or exposure to specific drug classes during fetal life. Large progress has been achieved in recent years toward understanding the biology of male and female reproduction in both animals and humans and applying this information to the creation of methods for fertility preservation in a variety of clinical and ecological contexts. Conclusions: A rapidly developing area, fertility preservation has a wide range of applications, from preserving the possibility of fertility in a child with cancer to preventing the extinction of an entire species. The emphasis on preserving fertility is now only placed on cancer patients who are of reproductive age, but its therapeutic importance may be extended to non-cancer patients as well.

  • Open Access

    Impact of sars-cov-2 virus on male urinary and reproductive system

    by Ion Dumbraveanu, Andrei Bradu, Iurii Arian, Mihaela Ivanov, Felicia Bulai, Emil Ceban

    SARS-CoV-2 virus affects all organs and systems of the human body, including urinary and reproductive. Covid-19 disease has symptoms, clinical evolution and unknown complications till our days. Based on urology-specific systematic literature review, the authors describe the epidemiology and mechanisms of male urinary and reproductive system damaged by SARS-CoV-2 virus. The pathogenesis of renal impairment in Covid-19 is multifactorial with direct action of the virus on the nephron, but especially due to factors generated by inflammatory process, intravascular coagulation, hypovolemia, cytokine storm or toxic drug action. The presence of kidney disease until infection with SARSCoV2 virus can be interpreted as a risk factor for the evolution of the disease. Covid-19 disease also has an impact on male sexual-reproductive function, due to erectile dysfunction, decreased sperm motility or hormonal influences. At the moment, there is no evidence about presence of the specific effective drug for the treatment of Covid-19, the only medical solution to avoid side effects of the disease, is and remains vaccination.